LanguageTerm (authority = ISO 639-3:2007); (type = text)
English
Abstract (type = abstract)
Extracellular matrix (ECM) is an intricate network of proteins, sugars, and proteoglycans that provides critical signaling context to resident cells through mechanical and bioactive properties. As such, the independent control of these features is a frequent target in the development of biomaterials. This research investigates the development of a bioink system based on thiol-modified hyaluronic acid (HA-S) and polyethylene glycol diacrylate (PEGDA) for 3D bioprinting. The objectives of this work were to (1) develop a versatile approach to independently control the mechanical and bioadhesive features of HAS-PEGDA across multiple time scales and (2) adapt the system to be amenable to 3D extrusion bioprinting.
To this end, we leveraged the distinct dual-crosslinking mechanism of HAS-PEGDA to control the mechanical properties at different time points. Rheological studies confirmed that two crosslinking reactions occur in HAS-PEGDA: (1) rapid crosslinking between HA-thiols and PEG-acrylates resulting in gelation in minutes and (2) prolonged disulfide crosslinking, which dramatically stiffens the network over a period of days-to-weeks. Like native HA, HAS-PEGDA does not support the adhesion of most healthy adult human cells, but the thiol modification provides a convenient target to introduce bioactive ligands. We demonstrated that the steady-state stiffness of the network can be manipulated independently of the initial crosslinking reaction by targeting a percentage of HA-thiols with peptide-ligands or inert spacers. Moreover, we identified ranges in which the mechanical and bioactive properties can be co-modulated in HAS-PEGDA, and we validated the biological functionality in vitro using human mesenchymal stem cells and rat dermal fibroblasts.
To adapt the formulation for 3D cell culture, reaction templates were developed to prioritize bioactive peptide-grafting, initial gelation, latent crosslinking, and network degradation, across time scales of seconds, minutes-to-hours, days, and weeks, respectively. Finally, we demonstrated that the time-dependent rheological features of HAS-PEGDA can be leveraged to formulate printable bioinks for extrusion-based 3D bioprinting. By harnessing the inherent viscoelastic features of HA, we identified a window of printing conditions that resulted in excellent cell viability, mechanical recovery, resolution, and bioink tunability. Taken together, the results presented in this thesis establish a customizable bioink system based on thiol-modified hyaluronic acid for extrusion-based bioprinting.
Subject (authority = LCSH)
Topic
Hyaluronic acid
Subject (authority = RUETD)
Topic
Biomedical Engineering
RelatedItem (type = host)
TitleInfo
Title
Rutgers University Electronic Theses and Dissertations
I hereby grant to the Rutgers University Libraries and to my school the non-exclusive right to archive, reproduce and distribute my thesis or dissertation, in whole or in part, and/or my abstract, in whole or in part, in and from an electronic format, subject to the release date subsequently stipulated in this submittal form and approved by my school. I represent and stipulate that the thesis or dissertation and its abstract are my original work, that they do not infringe or violate any rights of others, and that I make these grants as the sole owner of the rights to my thesis or dissertation and its abstract. I represent that I have obtained written permissions, when necessary, from the owner(s) of each third party copyrighted matter to be included in my thesis or dissertation and will supply copies of such upon request by my school. I acknowledge that RU ETD and my school will not distribute my thesis or dissertation or its abstract if, in their reasonable judgment, they believe all such rights have not been secured. I acknowledge that I retain ownership rights to the copyright of my work. I also retain the right to use all or part of this thesis or dissertation in future works, such as articles or books.